The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
pristane affects the expression of MIR26A mRNA Methotrexate inhibits the reaction [pristane results in decreased expression of MIR26A mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of IFNB1 mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TLR3 mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TLR3 protein]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TNF mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TNF protein]
Methotrexate inhibits the reaction [pristane results in increased expression of TLR3 mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TLR3 mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TLR3 protein] pristane results in increased expression of TLR3 mRNA; pristane results in increased expression of TLR3 protein
MIR26A mRNA inhibits the reaction [pristane results in increased expression of TNF mRNA]; MIR26A mRNA inhibits the reaction [pristane results in increased expression of TNF protein] pristane results in increased expression of TNF mRNA; pristane results in increased expression of TNF protein